ETF Channel Staff - Thursday, August 10, 10:31 AMLooking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR SSGA US Small Cap Low Volatility Index ETF (SMLV), we found that the implied analyst target price for the ETF based upon its underlying holdings is $120.91 per unit.
With SMLV trading at a recent price near $108.42 per unit, that means that analysts see 11.52% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of SMLV's underlying holdings with notable upside to their analyst target prices are Nuvation Bio Inc (NUVB), Clarus Corp (CLAR), and Artivion Inc (AORT). Although NUVB has traded at a recent price of $2.10/share, the average analyst target is 94.05% higher at $4.08/share. Similarly, CLAR has 56.00% upside from the recent share price of $8.76 if the average analyst target price of $13.67/share is reached, and analysts on average are expecting AORT to reach a target price of $25.30/share, which is 52.78% above the recent price of $16.56. Below is a twelve month price history chart comparing the stock performance of NUVB, CLAR, and AORT:
Below is a summary table of the current analyst target prices discussed above:
Name | Symbol | Recent Price | Avg. Analyst 12-Mo. Target | % Upside to Target |
---|---|---|---|---|
SPDR SSGA US Small Cap Low Volatility Index ETF | SMLV | $108.42 | $120.91 | 11.52% |
Nuvation Bio Inc | NUVB | $2.10 | $4.08 | 94.05% |
Clarus Corp | CLAR | $8.76 | $13.67 | 56.00% |
Artivion Inc | AORT | $16.56 | $25.30 | 52.78% |
Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.
The average analyst target price data upon which this article was based, is courtesy of data provided by Zacks Investment Research via Quandl.com.
Get the latest Zacks research report on NUVB — FREE
Get the latest Zacks research report on CLAR — FREE
Get the latest Zacks research report on AORT — FREE
Find the right mix of model portfolios today at PortfolioChannel.com
|
Free ETF Newsletter
|
Free Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Gold ETFs Silver ETFs Oil ETFs ETF Screens ETF Database ETF Guide |